semaglutide ckd approval Poll: Do you think we'll see new FDA for semaglutide, specifically or Heart Failure and/or CKD, in 2025? 💊 This post highlights primary takeaways from 2 major trials from the past ~ Novo's Ozempic wins FDA nod

BPC-157 is not specifically named on the WADA Prohibited List as a separately listed substance, but as a non-approved substance with no marketing authorization it may fall under WADA section S0 (Non-Approved Substances), which prohibits substances not addressed by other sections of the List that have no current approval for human therapeutic use

In PWS patients, groups without glucose intolerance had a significantly higher AG/DAG ratio than those with glucose intolerance [79]

Clinical trials have demonstrated the efficacy of semaglutide in promoting significant weight loss

Studies suggest that reducing these foods can improve weight management, as the body may burn twice as many calories digesting whole foods compared to processed ones

GLP-1 medications mimic this hormone and help you lose weight primarily through slowing down stomach emptying